🇺🇸 Liposomal Doxorubicin in United States

Liposomal Doxorubicin (liposomal-doxorubicin) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Liposomal Doxorubicin in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in United States

Frequently asked questions

Is Liposomal Doxorubicin approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Liposomal Doxorubicin in United States?

Pfizer is the originator. The local marketing authorisation holder may differ — check the official source linked above.